Skip to content

Free cash flow yield at other companies

TFX
TeleflexTFX
2.7%-0.5pp
Boston Scientific logo
Boston ScientificBSX
3.7%+1.7pp
Intuitive Surgical logo
Intuitive SurgicalISRG
1.7%+0.7pp
Absci Corporation logo
Absci CorporationABSI
-21.5%-2.1pp
UFP Technologies logo
UFP TechnologiesUFPT
3.9%+1.8pp
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
5.3%-3.7pp

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.22B-22.5%
Enterprise value$1.29B
P/S3.8×

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Calculated from PROCEPT BioRobotics Corporation’s reported figures.

Based on trailing twelve months.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's free cash flow yield?
PROCEPT BioRobotics Corporation (PRCT) reported free cash flow yield of -5.7% in Q1 2026.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.